» Articles » PMID: 32848701

Study of the Link Between Neuronal Death, Glial Response, and MAPK Pathway in Old Parkinsonian Mice

Overview
Specialty Geriatrics
Date 2020 Aug 28
PMID 32848701
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

: Parkinson's disease (PD) is described as an age-related neurodegenerative disorder. However, the vast majority of research is carried out using experimental models of young animals lacking the implications of the decline processes associated with aging. It has been suggested that several molecular pathways are involved in the perpetuation of the degeneration and the neuroinflammation in PD. Among others, mitogen-activated protein kinases (MAPKs) have been highly implicated in the development of PD, and regulating components of their activity are indicated as promising therapeutic targets. : To further define how MAPKs expression is related to the glial response and neuronal cell death, Parkinsonism was induced under an acute regimen in old mice. Moreover, the sacrifice was carried out at different time points (4, 8, 24, and 48 h) after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP) injections to describe the early dynamic changes over time produced by the intoxication. : The results revealed that neuronal death increases as glial response increases in the nigrostriatal pathway. It was observed that both processes increase from 4 h in the ventral mesencephalon (VM), and neuronal death becomes significant at 48 h. In the striatum, they were significantly increased from 48 h after the MPTP administration compared with that in the control mice. Moreover, the p-ERK levels decrease, while phospho-p38 expression increases specifically in the striatum at 48 h after MPTP intoxication. : The importance of these data lies in the possibility of elucidating the underlying mechanisms of neurodegenerative processes under aging conditions to provide knowledge for the search of solutions that slow down the progression of PD.

Citing Articles

Cdk5 and aberrant cell cycle activation at the core of neurodegeneration.

Requejo-Aguilar R Neural Regen Res. 2022; 18(6):1186-1190.

PMID: 36453392 PMC: 9838168. DOI: 10.4103/1673-5374.360165.


An edge-based statistical analysis of long non-coding RNA expression profiles reveals a negative association between Parkinson's disease and colon cancer.

Tian S, Zhang M, Ma Z BMC Med Genomics. 2021; 14(1):36.

PMID: 33531021 PMC: 7851899. DOI: 10.1186/s12920-021-00882-6.

References
1.
Thomas T, Timmer M, Cesnulevicius K, Hitti E, Kotlyarov A, Gaestel M . MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation--relevance in a mouse model of Parkinson's disease. J Neurochem. 2008; 105(5):2039-52. DOI: 10.1111/j.1471-4159.2008.05310.x. View

2.
Halliday G, Stevens C . Glia: initiators and progressors of pathology in Parkinson's disease. Mov Disord. 2011; 26(1):6-17. DOI: 10.1002/mds.23455. View

3.
Ray A, Sehgal N, Karunakaran S, Rangarajan G, Ravindranath V . MPTP activates ASK1-p38 MAPK signaling pathway through TNF-dependent Trx1 oxidation in parkinsonism mouse model. Free Radic Biol Med. 2015; 87:312-25. DOI: 10.1016/j.freeradbiomed.2015.06.041. View

4.
Stanciu M, Wang Y, Kentor R, Burke N, Watkins S, Kress G . Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J Biol Chem. 2000; 275(16):12200-6. DOI: 10.1074/jbc.275.16.12200. View

5.
Calabrese V, Santoro A, Monti D, Crupi R, Di Paola R, Latteri S . Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radic Biol Med. 2017; 115:80-91. DOI: 10.1016/j.freeradbiomed.2017.10.379. View